Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | EXECUTIVE VICE PRESIDENT | February 28, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 28, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 339,443 |
Reported balance
After 2023-02-28 transaction · row 1
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 6,247 · Balance 339,443 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $45.71 | $27,423.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 29 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,153 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,500 | $45.70 | $114,250.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 28 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,753 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.70 | $4,569.50 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 27 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,253 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,600 | $45.69 | $118,794.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 26 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,353 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.69 | $4,568.75 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 25 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,953 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 600 | $45.69 | $27,411.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 24 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,053 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,700 | $45.68 | $123,336.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 23 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,653 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.68 | $4,567.75 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 22 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,353 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $45.68 | $41,107.50 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 21 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,453 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,500 | $45.67 | $114,175.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 20 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,353 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $45.67 | $31,965.50 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 19 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,853 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,987 | $45.66 | $182,046.42 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 18 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,553 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.66 | $4,565.75 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 17 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,540 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $45.66 | $22,827.50 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 16 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,640 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,700 | $45.65 | $123,255.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 15 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,140 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $45.65 | $9,129.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 14 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,840 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $45.64 | $77,588.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 13 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,040 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $45.63 | $31,941.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 12 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,740 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $45.63 | $13,687.50 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 11 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,440 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 805 | $45.62 | $36,724.10 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 10 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,740 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $45.61 | $59,293.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 9 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,545 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $45.61 | $18,242.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 8 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,845 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,300 | $45.60 | $104,880.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 7 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,245 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $45.60 | $9,119.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 6 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,545 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $45.59 | $72,944.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 5 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,745 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,400 | $45.58 | $63,812.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 4 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,345 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.58 | $4,557.75 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 3 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,745 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.57 | $4,557.00 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 2 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,845 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 83,000 | $25.25 | $2,095,426.30 |
DisclosureSEC source: 0001179110-15-002007 · edgar.xml · nonDerivative · entry 1 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 309,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.82 | $4,581.75 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 30 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,880 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $45.82 | $22,907.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 29 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,980 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,300 | $45.81 | $196,983.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 28 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,480 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $45.81 | $18,323.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 27 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,780 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $45.81 | $41,224.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 26 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,180 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,373 | $45.80 | $62,883.40 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 25 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,080 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.80 | $4,579.75 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 24 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,453 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,800 | $45.80 | $82,431.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 23 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,553 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $45.79 | $18,316.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 22 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,353 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $45.79 | $9,157.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 21 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,753 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $45.79 | $50,363.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 20 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,953 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $45.78 | $73,248.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 19 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,053 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.78 | $4,577.75 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 18 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,653 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,400 | $45.78 | $109,860.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 17 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,753 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,000 | $45.77 | $183,080.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 16 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,153 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $45.77 | $4,576.75 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 15 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,153 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,016 | $45.77 | $138,027.24 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 14 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,253 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,384 | $45.76 | $63,331.84 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 13 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,269 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $45.76 | $9,151.50 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 12 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,653 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $45.76 | $18,302.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 11 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,853 Read SEC document |
| February 04, 2015 Filed Feb 6, 2015 22:11 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $45.75 | $41,175.00 |
DisclosureSEC source: 0001179110-15-002008 · edgar.xml · nonDerivative · entry 10 CAPEK JOHN M · CIK 0001328034 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,253 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.